A carregar...
Long-term efficacy and safety of iloperidone: an update
Schizophrenia is a devastating neuropsychiatric disease with a worldwide prevalence of approximately 0.5%–1%. Since many patients do not achieve adequate symptom relief from available agents, alternate pharmacotherapeutic approaches are needed. In this context, iloperidone was recently approved by t...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2014
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3942304/ https://ncbi.nlm.nih.gov/pubmed/24600226 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S37824 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|